SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
DNAPrint Genomics, Inc. (DNAG) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 17/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DNAG
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.03
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2001 |
$-0.20 |
$14.39K |
$-2.59M |
-18027% |
| 2002 |
$-0.14 |
$184.55K |
$-3.11M |
-1687.1% |
| 2003 |
$-3.20 |
$709.64K |
$-7.79M |
-1097.7% |
| 2004 |
$-0.20 |
$785.63K |
$-3.73M |
-475.4% |
| 2005 |
$-0.09 |
$1.28M |
$-8.72M |
-683.3% |
| 2006 |
$-0.03 |
$2.43M |
$-12.35M |
-507.5% |
